Correlation Between Bionano Genomics and BioLife Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionano Genomics and BioLife Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionano Genomics and BioLife Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionano Genomics and BioLife Sciences, you can compare the effects of market volatilities on Bionano Genomics and BioLife Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionano Genomics with a short position of BioLife Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionano Genomics and BioLife Sciences.

Diversification Opportunities for Bionano Genomics and BioLife Sciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bionano and BioLife is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bionano Genomics and BioLife Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLife Sciences and Bionano Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionano Genomics are associated (or correlated) with BioLife Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLife Sciences has no effect on the direction of Bionano Genomics i.e., Bionano Genomics and BioLife Sciences go up and down completely randomly.

Pair Corralation between Bionano Genomics and BioLife Sciences

Given the investment horizon of 90 days Bionano Genomics is expected to under-perform the BioLife Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Bionano Genomics is 16.42 times less risky than BioLife Sciences. The stock trades about -0.15 of its potential returns per unit of risk. The BioLife Sciences is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  0.20  in BioLife Sciences on November 2, 2024 and sell it today you would lose (0.19) from holding BioLife Sciences or give up 95.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Bionano Genomics  vs.  BioLife Sciences

 Performance 
       Timeline  
Bionano Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
BioLife Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLife Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BioLife Sciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Bionano Genomics and BioLife Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionano Genomics and BioLife Sciences

The main advantage of trading using opposite Bionano Genomics and BioLife Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionano Genomics position performs unexpectedly, BioLife Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Sciences will offset losses from the drop in BioLife Sciences' long position.
The idea behind Bionano Genomics and BioLife Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stocks Directory
Find actively traded stocks across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges